Cargando…

PReS-FINAL-2154: The early predictors of fatal outcome of macrophage activation syndrome in pediatric rheumatic diseases

Detalles Bibliográficos
Autores principales:	Kostik, MM, Abramova, NN, Snegireva, LS, Vasykina, LI, Dubko, MF, Masalova, VV, Kornishina, TL, Likhacheva, TS, Chikova, IA, Glebova, NI, Buchinskaya, NV, Kalashnikova, OV, Chasnyk, VG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042383/ http://dx.doi.org/10.1186/1546-0096-11-S2-P166

Ejemplares similares

PReS-FINAL-2233: Retrospective analysis of different treatment strategies in chronic non-bacterial osteomyelitis
por: Kostik, MM, et al.
Publicado: (2013)

Identification of the best cut-off points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis
por: Kostik, Mikhail M, et al.
Publicado: (2014)

Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis
por: Kostik, Mikhail M, et al.
Publicado: (2015)

Anemia in children with JIA: is it really driven by hepcidin level, or by a set of factors of a chronic disease
por: Egorov, Andrey, et al.
Publicado: (2014)

Rituximab Biosimilar BCD020 Shows Superior Efficacy above Conventional Non-Biologics Treatment in Pediatric Lupus Nephritis: The Data of Retrospective Cohort Study
por: Kostik, Mikhail, et al.
Publicado: (2023)

P03-006 - Pamidronate rapidly decreases CRP and TNFΑ in CNO
por: Kostik, MM, et al.
Publicado: (2013)

Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis
por: Kostik, Mikhail M., et al.
Publicado: (2022)

Comparison of different treatment approaches in chronic non-bacterial osteomyelitis.
por: Kostik, M, et al.
Publicado: (2015)

Uveitis Is a Risk Factor for Juvenile Idiopathic Arthritis' Significant Flare in Patients Treated With Biologics
por: Kostik, Mikhail M., et al.
Publicado: (2022)

The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
por: Kostik, Mikhail M., et al.
Publicado: (2022)

Distinguishing Between Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children and the Kawasaki Disease: Development of Preliminary Criteria Based on the Data of the Retrospective Multicenter Cohort Study
por: Kostik, Mikhail M., et al.
Publicado: (2021)

Differences in disease activity in cryopyrin-associated periodic syndrome in mutation-positive and mutation-negative patients
por: Kostik, M, et al.
Publicado: (2015)

Determination of Risk Factors for Severe Life-Threatening Course of Multisystem Inflammatory Syndrome Associated with COVID-19 in Children
por: Avrusin, Ilia S., et al.
Publicado: (2023)

Interleukine-6 and TNFα blockers provide only partial and short-term temporal improvement in cryopyrin-associated periodic syndrome
por: Dolgikh, Vladimir, et al.
Publicado: (2014)

PB2154: THE IMPACT OF DISEASE SEVERITY ON THE CLINICAL AND ECONOMIC BURDEN OF AL AMYLOIDOSIS
por: D’souza, Anita, et al.
Publicado: (2023)

PReS-FINAL-2293: An attempt to analyze variants of systemic lupus erythematosus onsets in childhood
por: Kuchinskaya, E, et al.
Publicado: (2013)

Heart Involvement in Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children: The Retrospective Multicenter Cohort Data
por: Kostik, Mikhail M., et al.
Publicado: (2022)

PB2154: TP53 GENE MUTATION DIVERSITY IN RUSSIAN PATIENTS WITH B-CELL LYMPHOMAS
por: Biderman, B., et al.
Publicado: (2022)

Lysophosphatidic acid receptor 1 antagonist (EPGN2154) causes regression of NASH in preclinical NASH models
por: Bhattacharjee, Jashdeep, et al.
Publicado: (2023)

COVID-19 Associated Vasculitis Confirmed by the Tissues RT-PCR: A Case Series Report
por: Belozerov, Konstantin E., et al.
Publicado: (2023)

Case report: Sulfasalazine-induced hypersensitivity
por: Kuchinskaya, Ekaterina M., et al.
Publicado: (2023)

2154. How Well Are We Estimating the True Burden of Acute Gastroenteritis? Validation of Acute Gastroenteritis-Related ICD Codes in Pediatric and Adult U.S. Populations
por: Pindyck, Talia, et al.
Publicado: (2018)

2154. Rapid Microorganism Identification From Blood and Enrichment Fluid Cultures Using MALDI-TOF Mass Spectrometry Following Abbreviated Incubation on Chocolate Agar Plates
por: Chew, Rusheng, et al.
Publicado: (2019)

2154. Cross-resistance of Ceftolozane-Tazobactam and Imipenem-Relebactam Against Clinical P. aeruginosa Isolates from Bloodstream and Respiratory Tract Infections– SMART United States 2019-2021
por: Lob, Sibylle, et al.
Publicado: (2023)

Pres & Sweets
por: Young, Lester, 1909-1959
Publicado: (1991)

The using of arthroscopy and synovial biopsy in chronic knee monoarthritis in children
por: Chicova, IA, et al.
Publicado: (2008)

PReS-FINAL-2167: What is the potential of intra-articular corticosteroid injections to induce sustained remission in children with juvenile idiopathic arthritis?
por: Lanni, S, et al.
Publicado: (2013)

Regression Models Predicting the Number of Deaths from the New Coronavirus Infection
por: Melik-Huseynov, D.V., et al.
Publicado: (2020)

iPRES 2018
Publicado: (2018)

Intracranial hypotension and PRES
por: Yang, Yi, et al.
Publicado: (2010)

PReS-FINAL-2113: The association of the NFKB1 gene polymorphism with systemic onset juvenile idiopathic arthritis in Russia
por: Malievsky, VA, et al.
Publicado: (2013)

PRES after spinal anesthesia
por: Takeuchi, Satoru, et al.
Publicado: (2011)

Hospitals and the Doctrine of "Cy-Pres"
Publicado: (1910)

A trombosis story and PRES
por: Kartal, Vural, et al.
Publicado: (2014)

Case Report: Altered with PRES
por: Dema, Fatima, et al.
Publicado: (2021)

Modernization of Regression Models to Predict the Number of Deaths from the New Coronavirus Infection
por: Karyakin, N.N., et al.
Publicado: (2020)

Identification of diagnostic criteria of septic complications in children with neutropenia
por: Furmanchuk, DA, et al.
Publicado: (2003)

Intracranial hypotension and PRES: a reply
por: Pugliese, S., et al.
Publicado: (2010)

Intracranial hypotension and PRES: case report
por: Pugliese, Silvia, et al.
Publicado: (2010)

Posterior reversible encephalopathy syndrome(PRES)
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rarp04mch9gvj3lrfl0a6iohfk